Nintedanib can be used safely and effectively for idiopathic pulmonary fibrosis with predicted forced vital capacity ≤ 50%: A multi-center retrospective analysis.
Senoo S, Miyahara N, Taniguchi A, Oda N, Itano J, Higo H, Hara N, Watanabe H, Kano H, Suwaki T, Fuchimoto Y, Kajimoto K, Ichikawa H, Kudo K, Shibayama T, Tanimoto Y, Kuyama S, Kanehiro A, Maeda Y, Kiura K; Okayama Respiratory Disease Study Group (ORDSG).
Senoo S, et al. Among authors: itano j.
PLoS One. 2020 Aug 27;15(8):e0236935. doi: 10.1371/journal.pone.0236935. eCollection 2020.
PLoS One. 2020.
PMID: 32853277
Free PMC article.